Open for recruitment
Trial summary
An early-phase clinical trial evaluating the safety, tolerability, and pharmacokinetics of subcutaneously dosed OM336 in adult participants with autoimmune cytopenias.
Trial details
Short title
OM336-AIC-1001
Diagnosis
Immune Thrombocytopenia (ITP)
Type of treatment
Haematology
Phase
I
Locations
Who can participate
Clinical trials can have restrictive criteria of who can and can’t participate, talk to your healthcare provider if you are interested in this clinical trial.